Eric Mayton is the President, CEO, and Chairman of the Board at Cerillo, a Charlottesville, VA based life sciences firm focused on removing boundaries of traditional equipment for scientific researchers. Eric spent the first decade of his career managing academic and commercial laboratories before earning his MBA from the University of Richmond in 2017. After stints in private equity and management consulting, Eric returned to the biotech industry in 2020 as CEO of Cerillo, a University of Virginia spin-out that was in early stages of commercialization efforts. In the first two years under Eric’s leadership, Cerillo has raised more than $3.5M in investment capital, tripled the size of the team, and signed over dozen commercial distribution partnerships. Eric holds a B.S. in Chemistry from the University of Virginia, a M.S. in Biochemistry from Virginia Commonwealth University, and a M.B.A from the University of Richmond.
